ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

2012 ACR/ARHP Annual Meeting

November 9-14, 2012. Washington, DC.

View by Title View Sessions
Jump to:  View All • [a] b c d e f g h i j k l m n o p q r s t u v w x y z
  • Abstract Number: 1547
    A 4 Plus 2 Infusion Protocol of Rituximab Provides Long-Term Beneficial Effects in Patients with HCV-Associated Mixed Cryoglobulinemia with Membranoproliferative Nephritis and Severe Polyneuropathy
  • Abstract Number: 296
    A Brazilian Multicenter Study of 71 Children and Adolescents with Takayasu’s Arteritis
  • Abstract Number: 1880
    A Brazilian Portuguese Validation of the Revised Fibromyalgia Impact Questionnaire (FIQR)
  • Abstract Number: 2439
    A Brief Exercise and Self Management Programme Improves Upper Limb Disability in People with Early Rheumatoid Arthritis
  • Abstract Number: 57
    A British Survey of Time to Presentation and Treatment of Rheumatoid Arthritis in Subjects of Black and Minority Ethnic Origin
  • Abstract Number: 774
    A CD4+ T-Cell Gene Expression Signature Predicts Drug Survival On Methotrexate Monotherapy in Early Rheumatoid Arthritis
  • Abstract Number: 2250
    A Clinical Analysis of Adult Patients with Autoimmune- and Infection-Associated Hemophagocytic Lymphohistiocytosis
  • Abstract Number: 1090
    A Comparison of Patient-Reported and Measured Range of Motion in a Cohort of Total Knee Replacement Patients
  • Abstract Number: 2243
    A Comparison of Systemic Lupus Erythematosus (SLE) Patients Achieving Prolonged Clinical Quiescence (PCQ) On and off Corticosteroids and/or Immunosuppressive Medications
  • Abstract Number: 804
    A Comparison of the Nociceptive Flexion Reflex, Pressure Algometry and Summated Widespread Pain in the Diagnosis of Fibromyalgia
  • Abstract Number: 1382
    A Comparison of Three Methods of Measuring Intermalleolar Distance in Patients with Ankylosing Spondylitis
  • Abstract Number: 1987
    A Comparison of Unilateral and Bilateral Hip BMD
  • Abstract Number: 1898
    A Competence-Based Model for Teaching Rheumatology in Undergraduate Medical Students in Pontificia Universidad Católica De Chile: A Five Years Experience
  • Abstract Number: 1940
    A Comprehensive Study of Novel Serum Markers of ILD Associated with Inflammatory Myopathies
  • Abstract Number: 136
    A Delphi Exercise to Identify Characteristic Features of Gout – A Study of Opinions From Patients and Physicians to Inform New Classification Criteria
  • Abstract Number: 1481
    A Double-Blind Placebo-Controlled Crossover Trial of the Alpha-2C Adrenoceptor Antagonist Orm-12741 for Prevention of Cold-Induced Vasospasm in Patients with Systemic Sclerosis
  • Abstract Number: 2619
    A Double-Blind Randomized Placebo-Controlled Trial of the Effect of Vitamin D3 On the Interferon Signature in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 861
    A Family Based Pedometer Walking Program in an Adolescent Population with Juvenile Idiopathic Arthritis
  • Abstract Number: 1100
    A Functional Growth Hormone Receptor Polymorphism, Exon 3 Deleted Ghr, Is Associated with Radiographic Knee Osteoarthritis in Females with Familial Osteoarthritis At Multiple Sites: The Garp Study
  • Abstract Number: 1760
    A Gene Expression Signature to Monitor Depletion of Plasma Cells Following MEDI-551 (anti-CD19) Administration
  • Abstract Number: 2323
    A Genetic Polymorphism on New Zealand Black Chromosome 1 Is Associated with Abnormal Dendritic Cell Function Leading to Expansion of TH1, TH17 and T Follicular Helper (TFH) Cells
  • Abstract Number: 2671
    A Genome-Wide Association Study Establishes Muliple Susceptibility Loci for Sjögren’s Syndrome
  • Abstract Number: 993
    A Genome-Wide DNA Methylation Analysis Reveals Different Methylation Patterns in the OA Disease
  • Abstract Number: 2370
    A Genome-Wide DNA Methylation Study Identifies Significant Epigenetic Changes Across the Genome and in Multiple HLA Loci in Behcet’s Disease
  • Abstract Number: 978
    A Genome-Wide Interaction Study with Smoking Suggests New Risk Loci for Two Different Subsets of Rheumatoid Arthritis; Results From Swedish Epidemiological Investigation of Rheumatoid Arthritis Study
  • Abstract Number: 595
    A Genomewide Association Study of Anterior Uveiti
  • Abstract Number: 2666
    A Link Between B Cells and Bone Erosion in RA: RANKL Production by Memory B Cells
  • Abstract Number: 2140
    A Longitudinal Study of Prognostic Factors in Patients with Early RA Providing Direction for Future Clinical Treatment- Predict Study
  • Abstract Number: 865
    A Methodology for Estimating Disease State Transitions: Repeated Measures Markov Models with Covariate Dependence
  • Abstract Number: 30
    A Mouse Myeloid Precursor with Osteoclastogenic Function in Vivo
  • Abstract Number: 2121
    A Multi-Biomarker Disease Activity (VECTRA™ DA Algorithm) Score Reflects Clinical Disease Activity and Structural Changes in Rheumatoid Arthritis Patients Treated with Tocilizumab
  • Abstract Number: 2664
    A Multi-Biomarker Disease Activity (VECTRA™ DA Algorithm) Score Reflects Clinical Disease Activity and Tracks Responses in Patients with Rheumatoid Arthritis Treated with Either Adalimumab, Etanercept, and Infliximab
  • Abstract Number: 2700
    A Multi-Center Study of the Appropriateness of Anti-Neutrophilic Cytoplasmic Antibody Testing
  • Abstract Number: 2030
    A Multi-Modal Amplified Musculoskeletal Pain Treatment Program: Associations of Previous Pharmacotherapy with Subsequent Outcomes
  • Abstract Number: 776
    A Multicenter, Randomized, Controlled, Open-Label Pilot Study of the Feasibility of Discontinuation of Adalimumab in Rheumatoid Arthritis Patients in Stable Clinical Remission
  • Abstract Number: 1409
    A Multicentre Clinical Study of Umbilical Cord Mesenchymal Stem Cells Transplantation in Active Systemic Lupus Erythematosus
  • Abstract Number: 920
    A Multimodal Intervention to Improve Osteoporosis Care in Home Health Settings: Results From a Cluster Randomized Trial
  • Abstract Number: 1009
    A New Approach for Detecting Progressive Joint Damage Using 3D Imaging From High-Resolution Peripheral Quantitative Computed Tomography: Measuring Reproducibility
  • Abstract Number: 1938
    A New Enzyme-Linked Immunosorbent Assay System for Detecting Autoantibodies to Aminoacyl-tRNA Synthetases: Clinical Usefulness in Myositis and Interstitial Pneumonia
  • Abstract Number: 1956
    A New Linked Set of Autoantibodies in Dermatomyositis: Anti-Mi-2 and Anti-Transcription Intermediary Factor (TIF) 1alpha
  • Abstract Number: 1155
    A New Measure of Visual Function for Children with Juvenile Idiopathic Arthritis-Associated Uveitis
  • Abstract Number: 511
    A New Pathogenic Role of Salivary Gland Epithelial Cells in the Costimulation of T Lymphocytes in Primary Sjögren’s Syndrome: 0X40 Ligand Expression, T-Cell Induction of OX40 and Promotion of T-Cell Survival, Proliferation and Activation
  • Abstract Number: 1806
    A Novel Angiopoetin2/TEK Tyrosine Kinase Receptor Mediated Effect On Leukocyte Cell Influx and Oxidative Damage in Inflammatory Arthritis
  • Abstract Number: 1592
    A Novel Approach to the Early Detection of Axial Spondyloarthritis in Patients with Inflammatory Bowel Disease: The Implementation of an Advanced Practice Physiotherapist Led Screening Program
  • Abstract Number: 676
    A Novel Biomarker: Nucleotide-Binding Oligomerization Domain 27 in Systemic Lupus Erythematosus
  • Abstract Number: 1311
    A Novel Individualized Treatment Approach in Open-Label Extension Study of Ozoralizumab (ATN-103) in Subjects with Rheumatoid Arthritis On a Background of Methotrexate
  • Abstract Number: 2328
    A Novel Method for Quantitative and Functional Analysis of Autophagy Using Flow Cytometry in Activated Human Primary T Cells
  • Abstract Number: 2019
    A Novel MRI Scoring System for the Evaluation of Early-Stage Disease Activity of the Wrist in Juvenile Idiopathic Arthritis
  • Abstract Number: 1742
    A Novel Murine Model of B Cell-Mediated Proteinuria Suggests Cytokines Mediate Podocyte Injury
  • Abstract Number: 738
    A Novel Orally Active Phosphatidylinositol 3-Phosphate 5-Kinase (PIKfyve) Inhibitor Ameliorates Mouse Psoriasis-Like Model by Inhibition of Interleukin-12 and Interleukin-23 Production From Macrophages
  • Abstract Number: 1637
    A Novel Peptide Inhibiting the Binding Between C1q and Immunoglobulin Ameliorates Joint Destruction in Rats with Collagen-Induced Arthritis
  • Abstract Number: 1457
    A Novel Small Molecular Anti-Rheumatic Drug, T-614, Ameliorates Lupus-Like Disease in MRL/Lpr Mice by Suppressing B Cell Functions
  • Abstract Number: 2333
    A Novel Subset of CD4 T Cells That Provides Help for Human Memory B Cell Responses
  • Abstract Number: 2340
    A Numeric Expansion of Invariant Natural Killer T Cells Protects Against the Progression of Fatal Autoimmunity in Lupus-Prone Mice
  • Abstract Number: 1875
    A Patient and Physician Survey of Impact and Management of Fibromyalgia Across Latin America and Europe
  • Abstract Number: 692
    A Phase 1 Multicenter, Open-Label Study of MEDI-546, a Human Anti-Type I Interferon Receptor Monoclonal Antibody, in Adults with Scleroderma
  • Abstract Number: 833
    A Phase 1, Randomized, Double-Blind, Placebo-Controlled Multiple-Dose Study of Intravenous Staphylococcal Protein A in Patients with Active Rheumatoid Arthritis On Methotrexate: Safety, Pharmacokinetics and Efficacy
  • Abstract Number: 1291
    A Phase Ib Clinical Trial with F8-IL10, an Anti-Inflammatory Immunocytokine for the Treatment of Rheumatoid Arthritis (RA), Used in Combination with Methotrexate (MTX)
  • Abstract Number: 1294
    A Phase Ib Multiple Ascending Dose Study Evaluating Safety, Pharmacokinetics, and Early Clinical Response of Brodalumab (AMG 827), a Human Anti-Interleukin 17 Receptor (IL-17R) Antibody, in Rheumatoid Arthritis
  • Abstract Number: 1339
    A Pilot Study Investigating the Tolerability and Pharmacodynamic Effect of Single Intravenous/Subcutaneous Doses of Olokizumab, an Anti-Interleukin-6 Monoclonal Antibody, in Patients with Rheumatoid Arthritis
  • Abstract Number: 135
    A Pilot Study of the Efficacy of IL1 Blockade by Anakinra in Acute Calcific Periarthritis of the Rotator Cuff
  • Abstract Number: 693
    A Placebo-Controlled Phase II Study of Hyperimmune Caprine Serum in Diffuse Cutaneous Systemic Sclerosis: Safety and Potential Efficacy
  • Abstract Number: 2256
    A Population of IL-21 Producing CD4+ T Cells Correlates with Disease Damage in Systemic Lupus Erythematosus (SLE) Patients
  • Abstract Number: 1521
    A Possible Contribution of Decreased Cathepsin V Expression to the Development of Dermal Fibrosis, Proliferative Vasculopathy, and Altered Keratinocyte Phenotype in Systemic Sclerosis
  • Abstract Number: 1504
    A Possible Contribution of Visfatin to the Resolution of Skin Sclerosis in Patients with Diffuse Cutaneous Systemic Sclerosis Via a Direct Anti-Fibrotic Effect On Dermal Fibroblasts and Th1 Polarization of the Immune Response
  • Abstract Number: 103
    A Pragmatic Musculoskeletal Ultrasound Screening Protocol Does Not Add to a Predictive Algorithm for Persistent Inflammatory Arthritis in a UK Early Arthritis Clinic
  • Abstract Number: 765
    A Prediction Rule for the Development of Rheumatoid Arthritis: A Prospective Cohort Study of Seropositive Arthralgia Patients
  • Abstract Number: 2096
    A Prediction Rule for the Progression to Rheumatoid Arthritis Applied in a Mexican Mestizo Cohort with Undifferentiated Arthritis
  • Abstract Number: 2405
    A Proof-of-Concept Study of an Animated, Web-Based Methotrexate Decision Aid for Patients with Rheumatoid Arthritis
  • Abstract Number: 2425
    A Qualitative Study of Self-Image and Body Image in Individuals with Systemic Lupus Erythematosus
  • Abstract Number: 1108
    A Randomized Controlled Trial of Hylan G-F 20 for the Treatment of Carpometacarpal Osteoarthritis
  • Abstract Number: 2473
    A Randomized Trial in New Onset Juvenile Dermatomyositis: Prednisone Versus Prednisone Plus Cyclosporine Versus Prednisone Plus Methotrexate
  • Abstract Number: 2545
    A Randomized, Double-Blind, Parallel Group Study of the Safety and Efficacy of Tocilizumab SC Versus Tocilizumab IV, in Combination with Traditional Dmards in Patients with Moderate to Severe RA
  • Abstract Number: L8
    A Randomized, Double-Blind, Parallel-Group Study of the Safety and Efficacy of Tocilizumab Subcutaneous Versus Placebo in Combination with Traditional Dmards in Patients with Moderate to Severe Rheumatoid Arthritis (BREVACTA)
  • Abstract Number: 831
    A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability, and Efficacy of Brodalumab (AMG 827) in Subjects with Rheumatoid Arthritis and an Inadequate Response to Methotrexate
  • Abstract Number: 2472
    A Randomized, Multicentre, Double Blind, Placebo-Controlled Trial of Anti TNF Alpha (adalimumab) in Refractory Hand Osteoarthritis: The Dora Study
  • Abstract Number: 549
    A Randomized, Open-Label Study of Maintenance of Partial Remission with Naproxen Vs No Treatment: Results of the Infliximab As First Line Therapy in Patients with Early Active Axial Spondyloarthritis Trial, Part II
  • Abstract Number: L1
    A Randomized, Placebo-Controlled Phase 2 Study of ARRY-797 in Patients with Osteoarthritis Pain Refractory to NSAID Treatment Showed Statistically Significant Improvements in WOMAC Pain and in Biomarkers of Bone and Cartilage Degradation
  • Abstract Number: 554
    A Reduction in Ultrasound Synovitis Score Discriminates Between Clinical Responders and Non-Responders and Is Predictive for a Favourable Clinical Outcome in Early Psoriartic Arthritis
  • Abstract Number: 1812
    A Retrospective Evaluation of the Clinical and Economic Implications of Gout in Nursing Home Residents in Hawaii Treated with Allopurinol
  • Abstract Number: 1753
    A Rheumatoid Factor Paradox: Inhibition of Rituximab-Induced Complement Dependent Cytotoxicity of B Cells
  • Abstract Number: 798
    A Rich Description of Clinical Exam Features in Patients with Knee Osteoarthritis and Their Correlation with Functional Outcomes
  • Abstract Number: 2564
    A Risk Score for Predicting Short-Term Incidence of Death or Relapse in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
  • Abstract Number: 899
    A Role for Soluble Interleukin-6 Receptor As an Antagonist of Interleukin-27 Signaling
  • Abstract Number: 1068
    A Selective Inhibitor of Endosomal Toll-Like Receptors, IMO-8400, Suppresses Activation of Multiple Cytokines, Th17 Response and Inflammasome Activation
  • Abstract Number: 1288
    A Significant Number of Patients with Chronic Arthritis Received a Reduced Dosage of Biological Drugs: an Observational Study in Clinical Practice
  • Abstract Number: 1186
    A Single Nucleotide Polymorphism of Tumor Necrosis Factor Receptor-Associated Factor 1 Predicts Clinical Response to Anti-Tumor Necrosis Factor Treatments in Japanese Patients with Rheumatoid Arthritis
  • Abstract Number: 1057
    A Specific Inhibitor of Spleen Tyrosine Kinase, PRT062607, Is a Potent Modulator of Innate Immune Cell Function
  • Abstract Number: 1380
    A Spondyloarthritis Research Consortium of Canada Score Cut-off ≥3 As Best Match for the Assessment of Spondyloarthritis International Society Definition of a Positive MRI of the Sacroiliac Joints
  • Abstract Number: 59
    A Staggering Burden of Pain and Rheumatic Disorders in India: A National Bone & Joint Decade India Community Oriented Program for Control of Rheumatic Disease Survey 2006-2011
  • Abstract Number: 183
    A Strong Association Between HLA-A*26 and Behçet’s Syndrome in Japanese Patients: From Two-Center Cohort Study of Behçet’s Syndrome
  • Abstract Number: 2653
    A Subset of up-Regulated IFN Regulated Genes in Candle Patients Decrease with Treatment with a JAK Inhibitor
  • Abstract Number: 1568
    A Survey Study of Methotrexate Use by Rheumatologists and Their Patients with Rheumatoid Arthritis
  • Abstract Number: 1447
    A Synthetic Triterpenoid CDDO-Me Prevents and Reverses Murine Lupus Nephritis
  • Abstract Number: 172
    A Systematic Review and Meta-Analysis of Antibiotic Treatment for Reactive Arthritis
  • Abstract Number: 966
    A Systematic Review of Evidence for the Effectiveness of Practitioner-Based Complementary and Alternative Therapies in the Management of Fibromyalgia
  • Abstract Number: 951
    A Systematic Review of Quality of Prognosis Studies in Systemic Lupus Erythematosus
  • Abstract Number: 731
    A Systems Biology Approach to Elucidating Pathways Active During the Development of Osteoarthritis
  • Abstract Number: 1456
    A Tolerogenic Peptide Down-Regulates the Expression of Interferon-a in Murine and Human Systemic Lupus Erythematosus
  • Abstract Number: 1004
    A Unique Single Nucleotide Polymorphism in the 3’ UTR of the MED29 Gene On Chromosome 19 Is Associated with the Clinical Outcome of Different Biologic Response Modifiers
  • Abstract Number: 56
    A Validated Mathematical Model Using Electronic Health Records to Identify Rheumatoid Arthritis Patients for Observational Studies
  • Abstract Number: 2663
    A Variant in the Osteoprotegerin Gene Is Associated with Coronary Atherosclerosis in Patients with Rheumatoid Arthritis: Results From a Candidate Gene Study
  • Abstract Number: 2469
    A Virtual Knee Joint Replacement Clinical Endpoint Based On Longitudinal Trends and Thresholds in Koos Knee Pain and Function in Osteoarthritis Initiative Participants
  • Abstract Number: 1978
    A Web-Based Intervention Aimed to Improve Bone Health Among Individuals On Chronic Glucocorticoids
  • Abstract Number: 1676
    Abatacept As First Line Biological Treatment for Severe Juvenile Idiopathic Arthritis-Related Uveitis. A Multicenter Study
  • Abstract Number: 1289
    Abatacept Biologic-Free Remission Study in Established Rheumatoid Arthritis Patients. Orion Study
  • Abstract Number: 2163
    Abatacept Monotherapy Effectively Reduces the Frequency of Osteoclast Precursor Cells in the Peripheral Blood of Patients with Rheumatoid Arthritis and Inhibits Their Differentiation Into Osteoclasts
  • Abstract Number: 787
    Aberrant Adipogenesis in the Pathogenesis of Scleroderma
  • Abstract Number: 877
    Aberrant Expression of BAFF Receptor (BR3) in Peripheral Monocytes of Patients with Primary Sjögren’s Syndrome Impacts Abnormal Activation of BAFF Signaling Through IKK-Alphaand IKK-Beta
  • Abstract Number: 660
    Abnormal Neutrophil Development in Human Systemic Lupus Erythematosus
  • Abstract Number: 1650
    Abnormal Serologies in the Absence of Clinical Activity Do Not Predict New or Recurrent Lupus Nephritis During Pregnancy
  • Abstract Number: 215
    Abnormal Videofluoroscopy Swallow Study Finding in Inflammatory Myopathy Patient with Dysphagia As Predictor of Prognosis
  • Abstract Number: 1248
    Accelerated Aging Influences Cardiovascular Disease Risk in Rheumatoid Arthritis
  • Abstract Number: 2067
    Access to Technology and Interest in Mobile “app” for Disease Management Among Patients with Systemic Lupus Erythematosus Seeking Care At a Large Referral Center
  • Abstract Number: 47
    Accumulation of CD34+ Hematopoietic Stem Cells in the Initial Inflammatory Human Fracture Hematoma Is Mediated Via Chemokine Receptor Type 3 Ligands
  • Abstract Number: 55
    Accuracy of Canadian Health Administrative Databases in Identifying Patients with Rheumatoid Arthritis Seen by Rheumatologists
  • Abstract Number: 926
    Accuracy of Canadian Health Administrative Databases in Identifying Patients with Rheumatoid Arthritis Using a Random Sample of 7500 Patients Seen in Primary Care
  • Abstract Number: 155
    Accuracy of International Classification of Disease Codes for Calcium Pyrophosphate Disease in the Veterans Adminstration Healthcare System
  • Abstract Number: 2447
    Accuracy of Sensewear MiniTM and Actigraph GT3XTM Accelerometers for Differentiating Sedentary and Light Physical Activities in a Controlled Laboratory Setting
  • Abstract Number: 302
    Accuracy of Systemic Lupus International Collaborating Clinics Classiffication Criteria Applied to Juvenile Systemic Lupus Erythematosus Patients
  • Abstract Number: 1813
    Accuracy of Veterans Affairs Database for Gout-Related Health Care Utilization
  • Abstract Number: 1303
    Achieving Comprehensive Disease Control in Long-Standing or Early Rheumatoid Arthritis Patients Treated with Adalimumab Plus Methotrexate Versus Methotrexate Alone
  • Abstract Number: 2011
    ACR Criteria, Providers’ Global Rating of Change and Role of Patient Self-Report in Evaluating Change in Disease Over Time: A Patient Reported Outcomes Measurement Information System Study
  • Abstract Number: 2299
    Acroosteolysis Is Associated with Increased Propensity for Osteoclast Formation and Higher VEGF Levels in the Peripheral Blood of Systemic Sclerosis Patients
  • Abstract Number: 2150
    Action of Tofacitinib Via Human Dendritic Cells
  • Abstract Number: 2507
    Activated Cullin-Ring Ubiquitin Ligases (CRLs) Dampen T Cell Signaling and Inactivation of Crls Arrests the Progression of Inflammatory Arthritis
  • Abstract Number: 2667
    Activated Memory B Cell Compartment in Rheumatoid Arthritis: Impact of B Cell Depletion Therapy
  • Abstract Number: 902
    Activation of NF-Kb Via Poly(I:C)-Induced Monocyte-Derived Microparticles Decreases TRAIL-Induced Apoptosis of Rheumatoid Arthritis Synovial Fibroblasts
  • Abstract Number: 1500
    Activation of Pregnane X Receptor Induces Regression of Experimental Dermal Fibrosis
  • Abstract Number: 1497
    Activation of Sirt1 Attenuates Bleomycin Induced Scleroderma Through Inhibiting Mammalian Target of Rapamycin Activation
  • Abstract Number: 25
    Activation of the Canonical Wnt Signaling Pathway Is Tissue Dependent in Osteoarthritic Joints: Distinct Mechanisms of Regulation by Wnt Antagonists
  • Abstract Number: 689
    Activation of the Interferon Pathway Is Dependent Upon Autoantibodies in African-American SLE Patients, but Not in European-American SLE Patients
  • Abstract Number: 479
    Active Immunization with TNF-Kinoid in Rheumatoid Arthritis Patients with Secondary Resistance to Tumor Necrosis Factor-Alpha Antagonists Is Safe and Immunogenic
  • Abstract Number: 607
    Activity Index After Renal Failure in a Cohort of 32 Patients with Lupus Nephritis
  • Abstract Number: 2446
    Activity Limitations Experienced by People with Rheumatoid Arthritis On Biologic Medications and Their Use of Ergonomic Methods
  • Abstract Number: 1148
    Adalimumab – Effective Control under Refractory JIA Associated Uveitis
  • Abstract Number: 5
    Adalimumab Inhibits TNF-Enhanced Human Osteoclast Development More Effectively Than Other Biologic Agents Under in Vitro Conditions of Chronic TNF Exposure
  • Abstract Number: 1352
    Adalimumab Significantly Reduces Recurrence Rate of Anterior Uveitis in Patients with Ankylosing Spondylitis
  • Abstract Number: 468
    Adalimumab Treatment Is Associated with Decreased Concomitant Rheumatoid Arthritis Medication Use Over 24 Months
  • Abstract Number: 16
    Adenosine A2A Receptor Diminishes Bone Destruction At Inflamed Sites, in Part, Via Downregulating Semaphorin4D-PlexinB1 Communication Between Osteoclasts and Osteoblasts
  • Abstract Number: 15
    Adenosine A2A Receptor Stimulation Inhibits OC Formation by Suppressing NFkB Translocation to the Nucleus by A PKA-ERK1/2 Mediated Mechanism
  • Abstract Number: 1778
    Adenosine A2A Receptor (A2AR) Activation Stimulates Increased Expression of Collagen-1 and Collagen-3 by Different Signaling Pathways in Normal Human Dermal Fibroblasts
  • Abstract Number: 2516
    Adenosine Receptors Stimulate Bone Regeneration by Targeting Osteoclasts
  • Abstract Number: 1965
    Adenosine Regulates Bone Metabolism Via A1, A2A and A2B Receptors in Bone Marrow Cells From Normal and Patients with Multiple Myeloma
  • Abstract Number: 2607
    Adherence to a Treat-to-Target Strategy in Early Rheumatoid Arthritis: Results of the Dutch Rheumatoid Arthritis Monitoring Remission Induction Cohort
  • Abstract Number: 634
    Adherence to Adult Treatment Panel III Guidelines for Systemic Lupus Patients
  • Abstract Number: 2289
    Adiponectin Has Potent Anti-Fibrotic Effects Mediated Via AMP Kinase: Novel Target for Fibrosis Therap
  • Abstract Number: 2097
    Adiponectin Is Associated with Pro-Inflammatory Cytokines in Autoantibody Positive First-Degree Relatives (FDRs) of Patients with Rheumatoid Arthritis
  • Abstract Number: 705
    Adipose Derived Stem Cells As an Alternative Source of Cellular Repair for Vascular Dysfunction in Systemic Sclerosis
  • Abstract Number: 260
    Adjudication of Reported Serious Adverse Joint Events in the Tanezumab Clinical Development Program
  • Abstract Number: 647
    Adjusted Framingham Risk Factor Scoring for Systemic Lupus Erythematosus: Results from an Inception Cohort Followed for Eight Years
  • Abstract Number: 2010
    Administration of Routine Preventative Vaccinations in Children with Juvenile Idiopathic Arthritis Receiving Adalimumab
  • Abstract Number: 1150
    Adverse Events in Juvenile Idiopathic Arthritis: Results From the Enhanced Drug Safety Surveillance (EDSS) Pilot Project
  • Abstract Number: 1136
    Aesthetic Dissatisfaction in Hand Osteoarthritis Patients, Its Impact and Risk Factors
  • Abstract Number: 1769
    Affinity Purification and Characterisation of Anti-CCP Antibodies From Plasma and Synovial Fluids of Patients with Rheumatoid Arthritis
  • Abstract Number: 1727
    Affinity Purified Antibodies Directed to Domain I of β2GPI Are Pathogenic in a Mouse Model of Thrombosis
  • Abstract Number: 796
    African American Adults Less Willing to Undergo Joint Replacement Surgery: The Multicenter Osteoarthritis Study
  • Abstract Number: 2145
    Age At Onset Determines Severity and  choice of Treatment in Early Rheumatoid Arthritis
  • Abstract Number: 1245
    Age-Specific Association Between Disease-Related Measures and Incident Cardiovascular Events and All-Cause Mortality in Early Rheumatoid Arthritis
  • Abstract Number: 981
    Aggregated Genetic Information Explains Variations On Hand Radiographic Scores in Rheumatoid Arthritis Patient
  • Abstract Number: 2136
    Alcohol Use and Radiographic Disease Progression in African Americans with Recent Onset Rheumatoid Arthritis
  • Abstract Number: 2117
    Algorithm Using Genome-Wide SNP Analysis for Prediction of Radiographic Progression Per Year in RA Patients From Multiple Medical Cohorts
  • Abstract Number: 2556
    Allogenic Mesenchymal Stem Cells Transplantation Alleviates Clinical Sjögren’s Syndrome
  • Abstract Number: 168
    Allopurinol Use Is Associated with a Decreased Risk of Myocardial Infarction
  • Abstract Number: 564
    Almost 40% of Patients with Chronic Back Pain Starting Before the Age of 45 Fulfill the ASAS Axial Spondyloarthritis Criteria
  • Abstract Number: 2238
    Alpha-Chlorofatty Acid Does Not Correlate with Baseline Subclinical Cardiovascular Disease in Systemic Lupus Erythematosus
  • Abstract Number: 408
    Alpha-Enolase Facilitates Migration of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis
  • Abstract Number: 2497
    Altered Circulating Follicular Helper T Cell Phenotype and Subset Composition Are Associated with Disease Activity in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 2287
    Altered Regulation of Metabolic Pathways in Systemic Sclerosis Evidenced by Metabolomics
  • Abstract Number: 674
    Altered Response to B Cell Receptor (BCR) Crosslinking in SLE: Correlation with Genetic Risk Variants Predicted to Impact BCR Signaling
  • Abstract Number: 2115
    Altered Serum Levels of Bone Metabolism Markers in Rheumatoid Arthritis
  • Abstract Number: 645
    Altered Soluble Inflammatory Mediators Mark Impending Systemic Lupus Erythematosus Disease Flare in European-American Lupus Patients Who Receive Influenza Vaccination
  • Abstract Number: 673
    Altered Soluble Mediators in Individuals with Incomplete Lupus (ILE) in the Lupus Autoimmunity in Relatives (LAUREL) Study
  • Abstract Number: 856
    Am80, a Retinoic Acid Receptor Agonist, Ameliorates Murine Vasculitisthrough the Suppression of Neutrophil Migration and Activation
  • Abstract Number: 1745
    Amelioration of Experimental Autoimmune Arthritis by Adoptive Transfer of Foxp3-Expressing Regulatory B Cells Is Associated with the Regulatory T Cell/T helper 17 cell Balance
  • Abstract Number: 210
    An Analysis of Metabolic Syndrome in Adult Dermatomyositis with a Focus On Cardiovascular Disease
  • Abstract Number: 768
    An Easy to Use Referral Model for Arthritis From the Rotterdam Early Arthitis Cohort
  • Abstract Number: 483
    An Evaluation of Literature On Discontinuation Rates of Biologics in Rheumatoid Arthritis
  • Abstract Number: 2131
    An Evaluation of Prognostic Factors for Orthopaedic Joint Surgery in Rheumatoid Arthritis. Results From Two Multicentre UK Inception Cohorts (1986-2011)
  • Abstract Number: 851
    An Evidence-Based Screening Algorithm for Pulmonary Arterial Hypertension in Systemic Sclerosis
  • Abstract Number: 2659
    An Expanded Repertoire of Anti-Citrullinated Peptide Antibodies Is Associated with Interstitial Lung Disease in Rheumatoid Arthritis
  • Abstract Number: 1296
    An Interim Analysis of the Efficacy of Abatacept in Japanese Biologics-naïve Rheumatoid Arthritis Patients (results from ABROAD study): Comparison of CRP and MMP-3 Level After Treatment with Abatacept Versus Anti-TNF Agents
  • Abstract Number: 2401
    An International Framework for Chronic Condition Self Management Support: Results from an International Electronic Consultation Process.
  • Abstract Number: 2457
    An Open-Label Prospective Pilot Mechanistic Study of Fluvastatin in Persistently Antiphospholipid Antibody-Positive Patients
  • Abstract Number: 1655
    An Open-Label Trial of Abatacept in Mild Relapsing Granulomatosis with Polyangiitis (Wegener’s)
  • Abstract Number: 2172
    An Update of Management of Coccidioidomycosis in Patients On Biologic Response Modifiers and Disease-Modifying Antirheumatic Drugs
  • Abstract Number: 1310
    Analysis of Anti-JC Polyomavirus T-Cell Immune Response with JC-Feron in Patients with Rheumatoid Arthritis Treated with Rituximab or Anti-TNF
  • Abstract Number: 761
    Analysis of Biomarkers in Systemic Juvenile Idiopathic Arthritis Patients On Canakinumab Therapy
  • Abstract Number: 2229
    Analysis of Clinical, CRP- and MRI- Responses to TNF-Blockade in Axial Spondyloarthritis Patients with Short Vs Long Symptom Duration
  • Abstract Number: 2143
    Analysis of Factors Associated with the Health Assessment Questionnaire Score Change in Five Years
  • Abstract Number: 392
    Analysis of Factors Impact On Patient Global Assessment in Daily Practice Based On Observational Cohort IORRA (Institute of Rheumatology, Rheumatoid Arthritis)
  • Abstract Number: 1196
    Analysis of Gene Expression Patterns in Rheumatoid  Arthritis (RA) Synovial Macrophages From Patients Undergoing Disease Flare
  • Abstract Number: 191
    Analysis of Genes Involved in Autoinflammatory Diseases in Adult Onset Still’s Disease
  • Abstract Number: 1015
    Analysis of Integrated Radiographic Data for Two Long-Term, Open-Label Extension Studies of Adalimumab
  • Abstract Number: 2057
    Analysis of the Adherence to the Monitoring of Glucocorticoid Eye Toxicity and of the Prevalence of Cataracts and Glaucoma Among Patients with Systemic Lupus Erythematosus
  • Abstract Number: 1614
    Analysis of the Immunochip in a Large Cohort of Juvenile Idiopathic Arthritis Cases Identifies 17 Loci At Genome-Wide Significance
  • Abstract Number: 1538
    ANCA-Associated Vasculitis in Hispanic Americans: An Unrecognized Severity
  • Abstract Number: 303
    Ancestral Group Differences in Pediatric SLE Early Disease Severity: An Analysis of the Carranet Registry
  • Abstract Number: 743
    Anemia and the Onset of Gout in a Population-Based Cohort of Adults: Atherosclerosis Risk in Communities Study
  • Abstract Number: 766
    Anemia May Provide Clinically Relevant Information Beyond Conventional Disease Activity Assessment to Predict Radiographic Damage Progression in Rheumatoid Arthritis
  • Abstract Number: 781
    Ankylosing Spondylitis Is Associated with an Increased Risk of Osteoporotic Fractures: A Population-Based Cohort Study
  • Abstract Number: 1612
    Ankylosing Spondylitis Is Associated with Single Nucleotide Polymorphisms in Loci Implicating Four Aminopeptidases
  • Abstract Number: 2213
    Ankylosing Spondylitis Is Strongly Related to Clinical Spine Fractures Independently of Drugs Use: A Register-Based Case-Control Study
  • Abstract Number: 2088
    Annexin A1 Receptor Agonist Suppresses Development of Inflammatory Arthritis
  • Abstract Number: 1732
    Annexin A5 Resistance Identifies a Subset of  Thrombosis Patients in Systemic Lupus Erythematosus
  • Abstract Number: 544
    Anterior Chest Wall Pain in Recent Inflammatory Back Pain. Data From the DESIR Cohort
  • Abstract Number: 1771
    Anti Carbamylated Protein Antibodies (Anti-CarP) Are Present in Arthralgia Patients and Predict the Development of Rheumatoid Arthritis
  • Abstract Number: 31
    Anti Citrullinated Protein Antibodies From Synovial Fluid of Rheumatoid Arthritis Patients Enhance Osteoclastogenesis
  • Abstract Number: 2581
    Anti- Citrullinated Protein Antibodies but Not Rheumatoid Factor Are Associated with Larger Bone Erosions in rheumatoid arthritis patients- a Cross-Sectional Micro Computed Tomography Study
  • Abstract Number: 1402
    Anti-ApoA1 Antibodies Associate with Disease Activity in Lupus and Are Lower in Patients Taking Hydroxychloroquine: A Longitudinal Analysis of 398 Samples
  • Abstract Number: 1605
    Anti-Citrullinated Peptide Autoantibodies to Rheumatoid Synovium Epitopes in Women and Risk of Future Rheumatoid Arthritis
  • Abstract Number: 27
    Anti-Citrullinated Protein Antibodies As an Indicator of Bone Damage in the Citrullinated Collagen Induced Arthritis Model
  • Abstract Number: 1201
    Anti-Citrullinated Protein Antibody Specific Fc Glycosylation Patterns in Arthralgia Patients
  • Abstract Number: 1200
    Anti-Cyclic Citrullinated Peptide Antibodies in Idiopathic Pulmonary Fibrosis Are Not Citrulline-Specific: Implications for the Pathogenesis of Rheumatoid Arthritis
  • Abstract Number: 325
    Anti-Cyclic Citrullinated Peptide Antibody Isotyping and Identification of Citrullinated Proteins in the Synovial Fluid of Juvenile Idiopathic Arthritis Patients
  • Abstract Number: 2156
    Anti-Cyclic Citrullinated Protein Antibodies As a Predictor of Response to Tocilizumab in Patients with Rheumatoid arthritis   A Prospective Study
  • Abstract Number: 1211
    ANTI-Cyclic Citrullinated Protein Antibodies Induce Inflammation and Oxidative Stress in WHITE Blood CELLS of Rheumatoid Arthritis Patients
  • Abstract Number: 2598
    Anti-Drug Antibodies Are Associated with Diminished Drug Levels and Treatment Failure
  • Abstract Number: 854
    Anti-EIF2B: A Novel Interstitial Lung Disease Associated Autoantibody in Patients with Systemic Sclerosis
  • Abstract Number: 1725
    ANTI-Factor Xa Antibodies ARE Significantly Increased in Patients with Systemic LUPUS Erythematosus and Antiphospholipid Syndrome
  • Abstract Number: 1796
    Anti-IL-20 Targets Local Tissue Inflammation As Opposed to Systemic Inflammation
  • Abstract Number: 1307
    Anti-IL-6 Receptor Nanobody (ALX-0061) Seamless “First-in-Human” Phase I/II POC Study in Patients with Active RA On Stable MTX Treatment
  • Abstract Number: 1662
    Anti-IL-6 Therapy Impairs Intestinal Repair Through Inhibition of Epithelial Proliferation After Injury
  • Abstract Number: 882
    Anti-Inflammatory Effects of Phosphodiesterase 4 Inhibition Are Mediated by Mitogen-Activated Protein Kinase Phosphatase-1
  • Abstract Number: 2079
    Anti-Interleukin-6 Receptor Antibody Improves Systemic Osteoporosis in a Mice Model of Glucose-6-Phosphate Isomerase-Induced Arthritis
  • Abstract Number: 1391
    Anti-Ku Autoantibodies in Systemic Lupus Erythematosus Versus Autoimmune Myositis As Measured by a Novel Chemiluminescence Assay
  • Abstract Number: 637
    Anti-Mullerian Hormone and Ovarian Reserve in Systemic Lupus Erythematosus
  • Abstract Number: 1403
    Anti-Nucleosome Antibodies Are Associated with Disease Activity and Hydroxychloroquine Use in Patients with Lupus: A Longitudinal, Multivariate Analysis of 398 Samples
  • Abstract Number: 1689
    Anti-Peptidylarginine Deiminase 3/4 Cross-Reactive Antibodies: A Novel Biomarker with Clinical and Mechanistic Implications in Rheumatoid Arthritis
  • Abstract Number: 2530
    Anti-Ribosomal P Antibodies in a Large Cohort of Autoimmune Hepatitis with No Evidence of Lupus: A Common Underlying Mechanism Targeting Liver?
  • Abstract Number: 1950
    Anti-Signal Recognition Particle Autoantibody ELISA Development and Validation: Utility in Patients with Necrotizing Myopathy
  • Abstract Number: 1776
    Anti-SSA/Ro Mediated Injury to the Endothelium Via Urokinase Plasminogen Activator Receptor/Tgfbeta Activation: Implications in the Pathogenesis of Congenital Heart Block
  • Abstract Number: 1992
    Anti-TNF Therapies Improve Bone Mineral Density At the Lumbar Spine of RA Patients by Decreasing Disease Activity and Suppressing Serum RANKL Levels
  • Abstract Number: 782
    Anti-TNF Therapy Slows Radiographic Progression of Ankylosing Spondylitis
  • Abstract Number: 1347
    Anti-TNFá Discontinuation in Psoriatic Arthritis: Is It Possible After Achieving Minimal Disease Activity?
  • Abstract Number: 1945
    Anti-Transcription Intermediary Factor 1-Gamma (TIF1-Υ) Autoantibody Detection by ELISA and Immunoprecipitation in a Prospective Myositis Cohort: Predictive Value for Cancer Associated Myositis
  • Abstract Number: 1949
    Anti-Transcription Intermediary Factor 1-Gamma (TIF1-Υ) Autoantibody ELISA Development and Validation
  • Abstract Number: 1338
    Anti-Tumor Necrosis Factor Therapy Reduces Serum Levels of Chemerin in Rheumatoid Arthritis: A New Mechanism by which Anti-Tumor Necrosis Factor Might Reduce Inflammation
  • Abstract Number: 1202
    Antibodies Against Porphyromonas Gingivalis Correlate with Rheumatoid Arthritis-Specific Auto-Immunity in Arthralgia Patients
  • Abstract Number: 177
    Antibodies to Citrullinated Peptides in Tuberculosis
  • Abstract Number: 422
    Antibodies to Citrulline From Rheumatoid Arthritis Patients Also Bind Homocitrulline
  • Abstract Number: 1286
    Antibodies to Etanercept and Adalimumab in Rheumatoid Arthritis Inadequate Responders and Clinical Outcomes After an Active Switch to Infliximab
  • Abstract Number: 1953
    Antibodies to NXP-2 and Transcriptional Intermediary Factor-Gamma Identify Patients with Cancer-Associated Dermatomyositis
  • Abstract Number: 677
    Antibodies to Oxidized Low Density Lipoprotein or Anti-Lipoprotein Lipase May Lead to More Atherosclerotic Plaque in a Sub-Set of SLE Patients
  • Abstract Number: 1748
    Antibody Secreting Cells Arising After Vaccination of Lupus Patients May Produce High Affinity Autoantibodies
  • Abstract Number: 948
    Antibody-Based Prediction Rules for Connective Tissue Disease: Analysis of 12,555 Patients with Antinuclear Antibody Testing
  • Abstract Number: 2190
    Antimalarials for Sjogren’s Syndrome Treatment in Adults, Meta-Analysis
  • Abstract Number: 1421
    Antimalarials Protect Systemic Lupus Erythematosus Patients From Damage Accrual During the First Five Years of the Disease
  • Abstract Number: 1730
    Antiphosphatidylethanolamine Is Not Associated with Thrombosis or Pregnancy Loss in Systemic Lupus Erythematosus
  • Abstract Number: 2366
    Aortic and Coronary Calcifications in Takayasu Arteritis
  • Abstract Number: 2255
    Apolipoprotein B Containing Lipoprotein Subclasses and Subclinical Atherosclerosis in Patients with Systemic Lupus Erythematosus (SLE)
  • Abstract Number: 729
    Apolipoprotein L1 Risk Variants Underlie Racial Disparities in Lupus Nephritis-Induced End-Stage Renal Disease
  • Abstract Number: 2237
    Application and Feasibility of Proposed Systemic Lupus Erythematosus Reproductive Health Care Quality Indicators At a Public Urban Rheumatology Clinic
  • Abstract Number: 2226
    Application of Classification Criteria for Psoriatic Arthritis to Patients of the Rotterdam Early Arthritis Cohort
  • Abstract Number: 1436
    Application of European League Against Rheumatism Recommendations for the Management of Systemic Lupus Erythematosus Patients with Neuropsychiatric Involvement May Limit Unnecessary Diagnostic Testing and Curve Intensification of Immunosuppressive Therapy of Unclear Benefit
  • Abstract Number: L13
    Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Results of a Phase 3, Randomized, Controlled Trial
  • Abstract Number: 1996
    Are Changes in Bone Mineral Density Different Between Groups of Early Rheumatoid Arthritis Patients Treated According to a Tight Control Strategy with or without Prednisone, If Osteoporosis Prophylaxis Is Applied?
  • Abstract Number: 2431
    Are Occupational Therapy Interventions Included in the Most Commonly Used European Clinical-Practice Guidelines for the Management of Osteoarthritis?
  • Abstract Number: 2050
    Are Patients Meeting the Updated Physical Activity Guidelines? Physical Activity Participation, Recommendation, and Preferences Among Adults with Rheumatic Diseases
  • Abstract Number: 494
    Are There Gender Specific Differences in Patient Characteristics At Initiation of Biologic Treatment in Rheumatoid Arthritis?
  • Abstract Number: 1632
    Arhalofenate Is a Novel Dual-Acting Agent with Uricosuric and Anti-Inflammatory Properties
  • Abstract Number: 702
    Arterial Stiffness Is Increased in Systemic Sclerosis: A Cross-Sectional Comparison with Matched Controls
  • Abstract Number: 2573
    Arthoplasty Rates Increased Among US Patients with Systemic Lupus Erythematosus: 1991-2005
  • Abstract Number: 2432
    Arthritis Foundation’s Tai Chi Program for People with Arthritis: One Year Follow-up
  • Abstract Number: 2416
    Arthritis-Attributable Interference in Routine Life Activities
  • Abstract Number: 12
    Articular Cartilage Expresses the IL-15 Receptor Alpha-Chain and Responds to IL-15 with Increased Matrix Metalloproteinase Release
  • Abstract Number: 1922
    Articular Involvement in Relapsing Polychondritis: A Case Series
  • Abstract Number: 2024
    Articular Symptoms in Cryopyrin-Associated Periodic Syndrome: Retrospective French Study
  • Abstract Number: 2604
    Ask a Doc – Rheumatologic Care Delivered Just in Time
  • Abstract Number: 2084
    ASP015K: A Novel JAK Inhibitor Demonstrated Potent Efficacy in Adjuvant-Induced Arthritis Model in Rats
  • Abstract Number: 2369
    Aspects of Innate Immunity in Behçet´s Disease: A Model of Autoinflammatory Disease?
  • Abstract Number: 2209
    Assessing Active Inflammation in Sacroiliac Joints in Spondyloarthritis Patients: No Added Value of Gadolinium Compared to Short Tau Inversion Recovery Sequence
  • Abstract Number: 1528
    Assessing Fatigue in Systemic Vasculitis From the Patient’s Perspective
  • Abstract Number: 2107
    Assessing Subclinical Synovitis in Rheumatoid Arthritis: Arthrosonographic Findings in Patients with Good Response to Therapy
  • Abstract Number: 2233
    Assessing the Clinical and Economic Burden of U.S. Veteran Ankylosing Spondylitis Patients
  • Abstract Number: 1038
    Assessment of Aortic Stiffness by Cardiac Magnetic Resonance Imaging in Systemic Autoimmune Rheumatic Diseases
  • Abstract Number: 1867
    Assessment of ART Therapy Program for Women with Fibromyalgia: Randomized, Controlled, Blinded Study
  • Abstract Number: 2363
    Assessment of Disease Activity in Large Vessel Vasculitis: Initial Results of an International Delphi Exercise
  • Abstract Number: 2591
    Assessment of Examination Skills of 4th Year Medical Students Using a Novel Objective Structured Clinical Examination
  • Abstract Number: 1972
    Assessment of Fracture Risk in Postmenopausal Women with Rheumatoid Arthritis
  • Abstract Number: 397
    Assessment of Global Disease Activity in Rheumatoid Arthritis Patients Monitored in the Measurement of Efficacy of Treatment in the Era of Rheumatology Database: The patient’s Versus the rheumatologist’s Opinion
  • Abstract Number: 810
    Assessment of Omeract Global Power Doppler Ultrasonography 44-Joint Scoring System and Reduced Joint Scoring Systems in Rheumatoid Arthritis Patients Treated with Abatacept Plus Background Methotrexate
  • Abstract Number: 2020
    Assessment of Procedure Safety and Cannula Position in Temporomandibular Joint Puncture Evaluated by Cone Beam Computerized Tomography
  • Abstract Number: 2600
    Assessment of Quality of Care for Incident Lupus Nephritis in the U.S. Medicaid Population
  • Abstract Number: 1043
    Assessment of Rheumatoid Arthritis Disease Activity by Power Doppler Ultrasonography: Association with Routine Clinical Indices and Its Usefulness in Detecting Remission
  • Abstract Number: 2690
    Assessment of Sleep Quality in Patients with Rheumatoid Arthritis
  • Abstract Number: 1160
    Assessment of Subclinical Synovitis by Power Doppler Ultrasonography in Patients with Juvenile Idiopathic Arthritis
  • Abstract Number: 578
    Assessment of the Link Between Inflammation and Fat Metaplasia in Patients with Spondyloarthritis On Non-Biological Therapy: A Long Term Magnetic Resonance Imaging Study
  • Abstract Number: 548
    Assessment of the T1-Weighted Sequence Is Essential in Defining a Positive MRI Scan of the Sacroiliac Joints in Spondyloarthritis
  • Abstract Number: 1050
    Assessment of Validity of Magnetic Resonance Imaging Measures of Joint Inflammation and Damage in Rheumatoid Arthritis Wrist/Hand – a Systematic Literature Review
  • Abstract Number: 2215
    Assessment of Vascular Age in Psoriatic Arthritis Patients
  • Abstract Number: 1396
    Associates of a History of Thrombosis in Systemic Lupus Erythematosus
  • Abstract Number: 828
    Association between Anti-Tumor Necrosis Factor Therapy and the Risk of Ischemic Stroke in Subjects with Rheumatoid Arthritis. Results From the British Society for Rheumatology Biologics Registers-Rheumatoid Arthritis (BSRBR-RA)
  • Abstract Number: 538
    Association Between Biomarkers (Metalloproteinase-3, Dikkopf-1 and Sclerostin) with Disease Activity and Prediction of Anti-TNFá Therapy Response in Patients with Ankylosing Spondylitis
  • Abstract Number: 1780
    Association Between Chondrocyte Hypertrophy and Angiogenesis of Cartilage in Osteoarthritis
  • Abstract Number: 1118
    Association Between Hip and Knee Cartilage Measured Using Radiographs and Magnetic Resonance Imaging: The Tasmanian Older Adult Cohort Study
  • Abstract Number: 1117
    Association Between Hip Bone Marrow Lesions (BMLs) and Bone Mineral Density: A Cross-Sectional and Longitudinal Population-Based Study
  • Abstract Number: 1258
    Association Between Low Vitamin D Levels and Indicators of Osteoporosis and Atherosclerosis
  • Abstract Number: 921
    Association Between Metabolic Syndrome and Bone Mineral Density in a Community-Dwelling Older Women: The São Paulo Ageing & Health Study (SPAH)
  • Abstract Number: 886
    Association Between Neutrophil Gene Signature and Disease Characteristics in Systemic Lupus Erythematosus Patients
  • Abstract Number: 237
    Association Between Pain Threshold, Symptoms and Radiographic Knee and Hip Osteoarthritis: The Johnston County Osteoarthritis Project
  • Abstract Number: 1259
    Association Between Subclinical Atherosclerosis and Bone Mineral Density in Rheumatoid Arthritis
  • Abstract Number: 1232
    Association of Actometer Assessed Physical Activity and Fatigue in Patients with Rheumatoid Arthritis: Patients with a Lower Daily Activity Have More Fatigue
  • Abstract Number: 971
    Association of adam33 Polymorphisms with Systemic Lupus Erythematosus
  • Abstract Number: 2513
    Association of Arthritis and Joint Pain with Accelerometer-Measured Physical Activity in Adults Aged 50 and Older in the United States: Findings From the National Health and Nutrition Examination Survey (2003-2004)
  • Abstract Number: 640
    Association of Body Weight with Cardiovascular Events in Systemic Lupus Erythematosus
  • Abstract Number: 1850
    Association of Clinical Trial Characteristics with Positive Study Outcome Reporting in Randomized Controlled Trials of Rheumatoid Arthritis Therapy
  • Abstract Number: 608
    Association of Discoid Lupus with Other Clinical Manifestations Among Patients with Systemic Lupus Erythematosus
  • Abstract Number: 984
    Association of Elevated C5a Levels, but Not the Presence of Anti-Cfh IgG Autoantibodies, with the Deletion of CFHR3 and CFHR1 in SLE
  • Abstract Number: 1467
    Association of Gastroesophageal Factors and Progression of Interstitial Lung Disease in the Canadian Scleroderma Research Group, a Large, Multicenter Database
  • Abstract Number: 2257
    Association of Low Vitamin D with High Disease Activity in an Australian Systemic Lupus Erythematosus Cohort
  • Abstract Number: 1866
    Association of Opioid Use with Symptom Severity and Quality of Life in Patients with Fibromyalgia
  • Abstract Number: 1252
    Association of Paraoxonase 1 Gene Polymorphisms and Enzyme Activity with Carotid Plaque in Rheumatoid Arthritis
  • Abstract Number: 584
    Association of Platelet Endothelial Cell Adhesion Molecule-1 and â1 Integrin Gene Polymorphisms with Uveitis Development in Ankylosing Spondylitis
  • Abstract Number: 821
    Association of Serum Uric Acid and Incident Fractures in Elderly Men
  • Abstract Number: 838
    Association of Urinary and Serum Soluble Fn14 Levels and TWEAK Levels with Lupus Nephritis Disease Activity
  • Abstract Number: 1711
    Association of Vascular Calcification and Perivascular Adipose Tissue of the Descending Aorta with Cardiovascular Events in SLE
  • Abstract Number: 998
    Association Study of Genetic Risk Variants for Psoriasis in a Large Cohort of Psoriatic Arthritis, Psoriasis and Controls of the Spanish Population and Association with Relevant Clinical Subphenotypes
  • Abstract Number: 2651
    Associations Between Body Mass Index and Physical Activity Following Total Knee Replacement
  • Abstract Number: 1683
    Associations Between Lipid and Rheumatoid Arthritis Genetic Factors, and Low Density Lipoprotein Levels in RA Patients
  • Abstract Number: 2629
    Associations of Current and Early-Life Socioeconomic Positions with Risk of Self-Reported Doctor-Diagnosed Arthritis in a Family-Medicine Cohort of North-Carolinians
  • Abstract Number: 793
    Associations of Foot Forces and Pressures to Regional Foot Pain: The Framingham Foot Study
  • Abstract Number: 792
    Associations of Foot Structure and Function to Low Back and Lower Extremity Pain
  • Abstract Number: 972
    Associations of Genetic Polymorphisms of Microrna-146a and Its Target Interleukin-1-Receptor-Associated Kinase 1 with Ankylosing Spondylitis
  • Abstract Number: 1665
    Associations of Race and Ethnicity with Overall Mortality and Cardiovascular Events Among Patients with End-Stage Renal Disease Due to Lupus Nephritis
  • Abstract Number: 2365
    Asymptomatic Myocardial Ischemic Disease in Takayasu’s Arteritis
  • Abstract Number: 648
    Atherosclerotic Vascular Events in a Multinational Inception Cohort of Systemic Lupus Erythematosus: Incidence Over a Ten Year Period
  • Abstract Number: 2149
    Atsttrin-â, an Engineered Protein Derived From Progranulin Growth Factor, Binds to TNF Receptors and Exhibits Potent Anti-Inflammatory Activity in Mice
  • Abstract Number: 1664
    Autoantibodies Are Associated with Subclinical Atherosclerosis and Cardiovascular Endpoints in Caucasian and African American Women in a Prospective Study:  the Multi-Ethnic Study of Atherosclerosis (MESA)
  • Abstract Number: 226
    Autoantibodies to Small Ubiquitin-Like Modifier Activating Enzymes in Japanese Patients with Dermatomyositis
  • Abstract Number: 712
    Autoantibodies to Survival of Motor Neuron (SMN) Complex Are Common in Patients with Anti-U1RNP/Sm and Are Associated with Features of Scleroderma and Myopathy
  • Abstract Number: 936
    Autoimmune Diseases: Declining Mortality Between 1999 and 2008 However Continuing to be a Leading Cause of Death in Children-A 10-Year Retrospective Review
  • Abstract Number: 987
    Autoimmune Susceptibility Genes Are Regulators of Gene Expression Response to ER Stress
  • Abstract Number: 1717
    Autologous Lipostructure in the Treatment of Fibrotic Perioral Changes in Systemic Sclerosis: A Pilot Study
  • Abstract Number: 1046
    Automated Breast Volume Scanner (ABVS), a New Automated Ultrasonic Device, Is Useful to Examine Joint Injury in Patients with Rheumatoid Arthritis
  • Abstract Number: 1943
    Autophagy Expressions Were Decreased in Circulating T Cells in Inflammatory Myopathies Patients
  • Abstract Number: 2081
    Avβ3 Integrin Inhibition with Cilengitide Both Prevents and Treats Collagen Induced Arthritis
  • Abstract Number: 2566
    Aβ-Related Angiitis: Comparison with Patients with Amyloid Cerebral Angiopathy without Inflammation
Jump to:  View All • [a] b c d e f g h i j k l m n o p q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology